These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
797 related items for PubMed ID: 16469603
1. Sacral neuromodulation in women with idiopathic detrusor overactivity incontinence: decreased overactivity but unchanged bladder contraction strength and urethral resistance during voiding. Groen J, Ruud Bosch JL, van Mastrigt R. J Urol; 2006 Mar; 175(3 Pt 1):1005-9; discussion 1009. PubMed ID: 16469603 [Abstract] [Full Text] [Related]
5. Long-term results of sacral nerve stimulation (S3) for the treatment of neurogenic refractory urge incontinence related to detrusor hyperreflexia. Chartier-Kastler EJ, Ruud Bosch JL, Perrigot M, Chancellor MB, Richard F, Denys P. J Urol; 2000 Nov; 164(5):1476-80. PubMed ID: 11025686 [Abstract] [Full Text] [Related]
6. Changes in urethral function with bladder filling in the presence of urodynamic stress incontinence and detrusor overactivity. Chaliha C, Digesu GA, Hutchings A, Khullar V. Am J Obstet Gynecol; 2005 Jan; 192(1):60-5. PubMed ID: 15672004 [Abstract] [Full Text] [Related]
7. Relationships between micturition urgency and involuntary voiding dynamics in men with urinary incontinence from idiopathic detrusor overactivity. Cucchi A, Quaglini S, Rovereto B. J Urol; 2007 Aug; 178(2):563-7; discussion 567. PubMed ID: 17570436 [Abstract] [Full Text] [Related]
8. Sacral neuromodulation for refractory detrusor overactivity in women with an artificial urinary sphincter. Roupret M, Chartier-Kastler E, Almeras C, Ayoub N, Haertig A, Richard F. J Urol; 2004 Jul; 172(1):236-9. PubMed ID: 15201782 [Abstract] [Full Text] [Related]
9. Chronic pudendal nerve neuromodulation in women with idiopathic refractory detrusor overactivity incontinence: results of a pilot study with a novel minimally invasive implantable mini-stimulator. Groen J, Amiel C, Bosch JL. Neurourol Urodyn; 2005 Jul; 24(3):226-30. PubMed ID: 15825153 [Abstract] [Full Text] [Related]
10. Urodynamic evidence of effectiveness of botulinum A toxin injection in treatment of detrusor overactivity refractory to anticholinergic agents. Kuo HC. Urology; 2004 May; 63(5):868-72. PubMed ID: 15134967 [Abstract] [Full Text] [Related]
18. Conventional and ambulatory urodynamic findings in women with symptoms suggestive of bladder overactivity. Radley SC, Rosario DJ, Chapple CR, Farkas AG. J Urol; 2001 Dec; 166(6):2253-8. PubMed ID: 11696746 [Abstract] [Full Text] [Related]
19. Antimuscarinic drug inhibits detrusor overactivity induced by topical application of prostaglandin E2 to the urethra with a decrease in urethral pressure. Yokoyama O, Miwa Y, Oyama N, Aoki Y, Ito H, Akino H. J Urol; 2007 Nov; 178(5):2208-12. PubMed ID: 17870108 [Abstract] [Full Text] [Related]
20. Urodynamic distinctions between idiopathic detrusor overactivity and detrusor overactivity secondary to multiple sclerosis. Lemack GE, Frohman EM, Zimmern PE, Hawker K, Ramnarayan P. Urology; 2006 May; 67(5):960-4. PubMed ID: 16635509 [Abstract] [Full Text] [Related] Page: [Next] [New Search]